Direct induction of human neurons from fibroblasts carrying the neuropsychiatric 22q11.2 microdeletion reveals transcriptome- and epigenome-wide alterations
Carolin PurmanniD, Cheen Euong AngiD, Koji Tanabe, Yue ZhangiD, Soumya KunduiD, Tamás DankóiD, Shining MaiD, Alexis MitelpunktiD, Wing Hung WongiD, Jonathan Adam BernsteiniD, Joachim Franz HallmayeriD, Bruce J. AronowiD, Thomas Christian SüdhofiD, Anshul Bharat KundajeiD, Marius WernigiD, Alexander Eckehart UrbaniD
Abstract
Standard methods for the creation of neuronal cells via direct induction from primary tissue use perinatal fibroblasts, which hinders the important study of patient specific genetic lesions such as those underlying neuropsychiatric disorders. To address this we developed a novel method for the direct induction of neuronal cells (induced neuronal cells, iN cells) from adult human fibroblast cells. Reprogramming fibroblasts into iN cells via recombinant virus resulted in cells that stain for markers such as MAP2 and PSA-NCAM and exhibit electrophysiological properties such as action potentials and voltage dependent sodium- and potassium currents that reveal a neuronal phenotype. Transcriptome and chromatin analysis using RNA-Seq, microRNA-Seq and ATAC-Seq, respectively, further confirm neuronal character. 22q11.2 Deletion-Syndrome (22q11DS) is caused by a large 3 million base-pair heterozygous deletion on human chromosome 22 and is strongly associated with neurodevelopmental, neuropsychiatric phenotypes such as schizophrenia and autism. We leverage the direct-iN cell model for the study of genetic neurodevelopmental conditions by presenting gene-by-gene as well as networkwide effects of the 22q11DS deletion on gene expression in human neuronal cells, on several levels of functional genomics analysis. Some of the genes within the 22q11DS deletion boundary exhibit unexpected cell-type-specific changes in transcript levels, and genome-wide we can detect dysregulation of calcium channel subunit genes and other genes known to be involved in autism or schizophrenia, such as NRXN1, as well synaptic pathways. This genome-wide effect on gene expression can also be observed at the microRNA and chromatin levels, showing that the iN cells have indeed converted to a neuronal phenotype at several regulatory levels: chromatin, protein-coding RNAs and microRNAs, revealing relevant disease pathways and genes. We present this model of inducing neurons from fibroblasts as a useful general resource to study the genetic and molecular basis of normal and abnormal brain development and brain function.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synaptic microRNA dysregulation orchestrates aberrant glutamatergic transmission in a human neuronal model of 22q11.2 deletion syndrome
Weibo Niu, Jidong Guo, … Zhexing Wen·bioRxiv·Oct 15, 2026
- A CRISPR-engineered Isogenic Model Reveals Altered Neuronal Phenotypes of the 22q11.2 A-B Syndromic Deletion
Neha Paranjape, Yu-Hsiu Tony Lin, … Arun P. Wiita·bioRxiv·Jun 22, 2022
- Transient disruption of progenitor states and layer 2/3 projection neuron generation in frontal association cortex due to 22q11.2 gene deletion
Shah Rukh, Daniel W. Meechan, … Anthony‐Samuel LaMantia·bioRxiv·May 12, 2025
- Altered development and network connectivity in a human neuronal model of 15q11.2 deletion-related neurodevelopmental disorders
Christa Whelan Habela, Shiyu Liu, … Nicholas John Maragakis·Translational PsychiatryPeer-reviewed·Aug 29, 2025
- Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia
Sneha B. Rao, Zhixiong Sun, … Joseph A. Gogos·Nature CommunicationsPeer-reviewed·Aug 1, 2025
- Using induced pluripotent stem cells to investigate human neuronal phenotypes in 1q21.1 deletion and duplication syndrome.
Gareth Chapman, Mouhamed Alsaqati, … Yasir Ahmed Syed·Molecular PsychiatryPeer-reviewed·Jun 10, 2021